Brain Gain: Supplements And Nutraceuticals Expand Cognitive Health Science
This article was originally published in The Tan Sheet
The next generation of substances to slow cognitive decline and perhaps even prevent Alzheimer's disease may take a test run through the dietary supplement and nutraceutical markets
You may also be interested in...
A capital infusion from the investment group DaneVest Tech Fund I will help Quincy Bioscience market its "novel" dietary supplement Prevagen, the Madison, Wis.-based biotech announces Aug. 25. Quincy launched the brain cell protection supplement in 2007 and says the unquantified investment "will accelerate our goal to make Prevagen a national brand" (1"The Tan Sheet" Aug. 10, 2009). Prevagen's active ingredient apoaequorin comes from jellyfish and is a calcium-binding protein that helps buffer excess calcium from damaging aging neurons, Quincy says
Bioenergy Life Science exemplifies what many believe is the future of the nutritional industry - a firm steeped in science with feet in the supplement and pharmaceutical areas
A multi-nutrient drink under development by Group Danone improved memory in patients with mild Alzheimer's disease, according to a 12-week randomized, double-blind controlled trial with 225 "drug-naive" Alzheimer's patients